Skip to content
Open access

Large-scale proteomics to identify novel biomarkers linking social determinants of health to heart failure risk

Aug 2026 · Science Advances · Vol 12 · 0 citations · 79 references
Medicine

TL;DR

Protein biomarkers associated with SDOH burden and HF risk are demonstrated and potentially causal effect of C1q tumor necrosis factor–related protein 1 (C1QTNF1), an adiponectin paralog, on HF is suggested.

Abstract

Adverse social determinants of health (SDOH) associate with greater heart failure (HF) risk. Among 9879 community-based participants of the Atherosclerosis Risk in Communities (ARIC) cohort study, we assessed 4955 plasma proteins using an aptamer-based platform (SomaLogic). We derived an SDOH factor comprising income, education, and area deprivation index (ADI) in Black and white participants. Proteins associated with this factor at Bonferroni significance were tested for associations with incident HF using multivariable Cox proportional hazard models. Among Black participants, 36 proteins were associated with both the SDOH factor and incident HF, 126 were among white participants, and 12 were shared between race strata. Eight of these demonstrated significant mediation effect in causal mediation models. Key results were replicated in 49,396 participants in UK Biobank. Mendelian randomization and colocalization suggested a potentially causal effect of C1q tumor necrosis factor–related protein 1 (C1QTNF1), an adiponectin paralog, on HF. We demonstrate protein biomarkers associated with SDOH burden and HF risk.

Read PDF

Similar papers

Open access Sep 2026

Proteome-wide genetic analyses identify ASGR1 as a potential biomarker linking smoking with ischemic heart disease

Tobacco smoking increases the risk of multiple diseases, but the biological mechanisms involved remain incompletely understood. Here we characterize smoking-related protein profiles to identify potentially causal biomarkers mediating smoking’s effects. In European-ancestry populations, genetically predicted smoking exp...

A. Tinworth, P. Yao, A. Iona et al. · 0 citations
Aug 2026

Metabolites Associated With Long-Term Risk of Peripheral Artery Disease: The ARIC Study.

Distinct metabolomic profiles were associated with incident PAD and CLI years before clinical onset, highlighting dysregulated glycemic control, impaired redox balance, and altered lipid remodeling as key underlying pathways and suggest that circulating metabolites may serve as early indicators of metabolic health rele...

E. Bansah, Xiao Hu, S. Ballew et al. · 0 citations
Open access Sep 2026

Sex-specific associations of the plasma-proteome with incident coronary artery disease.

AIMS The etiology of coronary artery Disease (CAD) appears different for men and women, yet insights into underlying sex-specific biological mechanisms are limited. We integrated genomic and proteomic analyses to investigate sex-specific associations of the plasma-proteome with CAD. METHODS AND RESULTS In 40,829 UK B...

V. Sier, K. Dimitrova, E. Peters et al. · 0 citations
Open access Aug 2026

Circulating lipids, lipoproteins, and the risk of idiopathic pulmonary fibrosis: a cohort study and genetic analysis

Triangulating evidence across approaches, Mendelian randomization analyses supported inverse associations of genetically predicted total cholesteryl esters and sphingomyelins with IPF risk, and highlights cholesterol and sphingolipid metabolism as potential contributors to IPF susceptibility.

Jiahao Zhu, Yu-Hao Shen, Zhe-An Yan et al. · 0 citations
Open access Sep 2026

Identification of Plasma Protein Biomarkers for Early-Onset Stroke through Mendelian Randomization

This large-scale proteome-wide Mendelian randomization study identified multiple plasma proteins with likely causal roles in EOS, implicating coagulation, platelet activation, extracellular matrix remodeling, and immune pathways in disease etiology.

A. Huynh, B. Gaynor, J. W. Cole et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.